• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染因子并非小鼠动脉粥样硬化形成所必需。

Infectious agents are not necessary for murine atherogenesis.

作者信息

Wright S D, Burton C, Hernandez M, Hassing H, Montenegro J, Mundt S, Patel S, Card D J, Hermanowski-Vosatka A, Bergstrom J D, Sparrow C P, Detmers P A, Chao Y S

机构信息

Department of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065, USA.

出版信息

J Exp Med. 2000 Apr 17;191(8):1437-42. doi: 10.1084/jem.191.8.1437.

DOI:10.1084/jem.191.8.1437
PMID:10770809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2193142/
Abstract

Recent work has revealed correlations between bacterial or viral infections and atherosclerotic disease. One particular bacterium, Chlamydia pneumoniae, has been observed at high frequency in human atherosclerotic lesions, prompting the hypothesis that infectious agents may be necessary for the initiation or progression of atherosclerosis. To determine if responses to gram-negative bacteria are necessary for atherogenesis, we first bred atherosclerosis-prone apolipoprotein (apo) E(-/)- (deficient) mice with animals incapable of responding to bacterial lipopolysaccharide. Atherogenesis was unaffected in doubly deficient animals. We further tested the role of infectious agents by creating a colony of germ-free apo E(-/)- mice. These animals are free of all microbial agents (bacterial, viral, and fungal). Atherosclerosis in germ-free animals was not measurably different from that in animals raised with ambient levels of microbial challenge. These studies show that infection is not necessary for murine atherosclerosis and that, unlike peptic ulcer, Koch's postulates cannot be fulfilled for any infectious agent in atherosclerosis.

摘要

近期的研究揭示了细菌或病毒感染与动脉粥样硬化疾病之间的关联。一种特殊的细菌,肺炎衣原体,在人类动脉粥样硬化病变中被高频观察到,这促使人们提出假说,即感染因子可能是动脉粥样硬化起始或进展所必需的。为了确定对革兰氏阴性菌的反应是否是动脉粥样硬化发生所必需的,我们首先将易患动脉粥样硬化的载脂蛋白(apo)E基因敲除(缺陷)小鼠与无法对细菌脂多糖作出反应的动物进行杂交。在双缺陷动物中,动脉粥样硬化的发生未受影响。我们通过培育无菌的apo E基因敲除小鼠群体进一步测试了感染因子的作用。这些动物没有任何微生物因子(细菌、病毒和真菌)。无菌动物的动脉粥样硬化与在有环境水平微生物挑战的情况下饲养的动物相比,没有明显差异。这些研究表明,感染对于小鼠动脉粥样硬化并非必需,并且与消化性溃疡不同,对于动脉粥样硬化中的任何感染因子,科赫法则都无法得到满足。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e9/2193142/ebc8a6cc3844/JEM992326.f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e9/2193142/fe5fdacb5fd3/JEM992326.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e9/2193142/f64144ca357e/JEM992326.f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e9/2193142/ebc8a6cc3844/JEM992326.f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e9/2193142/fe5fdacb5fd3/JEM992326.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e9/2193142/f64144ca357e/JEM992326.f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e9/2193142/ebc8a6cc3844/JEM992326.f3.jpg

相似文献

1
Infectious agents are not necessary for murine atherogenesis.感染因子并非小鼠动脉粥样硬化形成所必需。
J Exp Med. 2000 Apr 17;191(8):1437-42. doi: 10.1084/jem.191.8.1437.
2
Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.肺炎衣原体感染不会在小鼠中诱发或改变动脉粥样硬化。
Circulation. 2001 Jun 12;103(23):2834-8. doi: 10.1161/01.cir.103.23.2834.
3
Murine models of Chlamydia pneumoniae infection and atherosclerosis.肺炎衣原体感染与动脉粥样硬化的小鼠模型。
J Infect Dis. 1997 Apr;175(4):883-90. doi: 10.1086/513986.
4
Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.肺炎衣原体感染加速载脂蛋白E缺乏小鼠的动脉粥样硬化进程。
J Infect Dis. 1999 Jul;180(1):238-41. doi: 10.1086/314855.
5
Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.肺炎衣原体不会增加载脂蛋白E缺乏小鼠主动脉根部的动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):578-84. doi: 10.1161/01.atv.21.4.578.
6
Mouse models of Chlamydia pneumoniae infection and atherosclerosis.肺炎衣原体感染与动脉粥样硬化的小鼠模型。
Am Heart J. 1999 Nov;138(5 Pt 2):S516-8. doi: 10.1016/s0002-8703(99)70290-5.
7
Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.阿奇霉素对肺炎衣原体加剧的小鼠动脉硬化的影响。
J Infect Dis. 2001 Jan 15;183(2):232-238. doi: 10.1086/317941. Epub 2000 Dec 13.
8
Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.白细胞介素-1受体信号传导在小鼠载脂蛋白E杂合子模型中介导与细菌暴露和/或高脂饮食相关的动脉粥样硬化:药物治疗意义。
Circulation. 2004 Sep 21;110(12):1678-85. doi: 10.1161/01.CIR.0000142085.39015.31. Epub 2004 Sep 7.
9
Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice.
Am J Pathol. 1997 May;150(5):1687-99.
10
Effect of Chlamydia trachomatis infection on atherosclerosis in apolipoprotein E-deficient mice.沙眼衣原体感染对载脂蛋白E缺乏小鼠动脉粥样硬化的影响。
Infect Immun. 2000 Dec;68(12):7195-7. doi: 10.1128/IAI.68.12.7195-7197.2000.

引用本文的文献

1
Gut Microbiota and Microbial Metabolism in Early Risk of Cardiometabolic Disease.肠道微生物群和微生物代谢与心血管代谢疾病的早期风险。
Circ Res. 2023 Jun 9;132(12):1674-1691. doi: 10.1161/CIRCRESAHA.123.322055. Epub 2023 Jun 8.
2
The IL-1 Family and Its Role in Atherosclerosis.IL-1 家族及其在动脉粥样硬化中的作用。
Int J Mol Sci. 2022 Dec 20;24(1):17. doi: 10.3390/ijms24010017.
3
LDL delivery of microbial small RNAs drives atherosclerosis through macrophage TLR8.LDL 递送的微生物小分子 RNA 通过巨噬细胞 TLR8 促进动脉粥样硬化。

本文引用的文献

1
A simple method for the isolation and purification of total lipides from animal tissues.一种从动物组织中分离和纯化总脂质的简单方法。
J Biol Chem. 1957 May;226(1):497-509.
2
Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis.肺炎衣原体血清阳性与颈动脉粥样硬化之间无关联。
Am J Cardiol. 1999 Oct 1;84(7):825-8. doi: 10.1016/s0002-9149(99)00445-2.
3
Does Chlamydia pneumoniae cause atherosclerosis?
Arch Surg. 1999 Sep;134(9):930-4. doi: 10.1001/archsurg.134.9.930.
Nat Cell Biol. 2022 Dec;24(12):1701-1713. doi: 10.1038/s41556-022-01030-7. Epub 2022 Dec 6.
4
Circulating gut microbiota-related metabolites influence endothelium plaque lesion formation in ApoE knockout rats.循环肠道微生物群相关代谢物影响载脂蛋白 E 基因敲除大鼠的动脉粥样硬化斑块形成。
PLoS One. 2022 May 6;17(5):e0264934. doi: 10.1371/journal.pone.0264934. eCollection 2022.
5
Network of Interactions Between Gut Microbiome, Host Biomarkers, and Urine Metabolome in Carotid Atherosclerosis.肠道微生物组、宿主生物标志物和颈动脉粥样硬化尿液代谢组之间的相互作用网络。
Front Cell Infect Microbiol. 2021 Oct 7;11:708088. doi: 10.3389/fcimb.2021.708088. eCollection 2021.
6
Implication of Gut Microbiota in Cardiovascular Diseases.肠道微生物群在心血管疾病中的意义。
Oxid Med Cell Longev. 2020 Sep 26;2020:5394096. doi: 10.1155/2020/5394096. eCollection 2020.
7
Mitochondrial Contact Sites in Inflammation-Induced Cardiovascular Disease.炎症诱导的心血管疾病中的线粒体接触位点
Front Cell Dev Biol. 2020 Jul 30;8:692. doi: 10.3389/fcell.2020.00692. eCollection 2020.
8
Mechanisms of NLRP3 priming in inflammaging and age related diseases.NLRP3 预激活在炎症衰老和与年龄相关疾病中的机制。
Cytokine Growth Factor Rev. 2020 Oct;55:15-25. doi: 10.1016/j.cytogfr.2020.08.003. Epub 2020 Aug 24.
9
Germ-free housing conditions do not affect aortic root and aortic arch lesion size of late atherosclerotic low-density lipoprotein receptor-deficient mice.无菌饲养条件不影响晚期动脉粥样硬化性低密度脂蛋白受体缺陷型小鼠的主动脉根部和主动脉弓病变大小。
Gut Microbes. 2020 Nov 1;11(6):1809-1823. doi: 10.1080/19490976.2020.1767463. Epub 2020 Jun 24.
10
Trimethylamine N-Oxide in Relation to Cardiometabolic Health-Cause or Effect?三甲基胺 N-氧化物与心脏代谢健康的关系——是原因还是结果?
Nutrients. 2020 May 7;12(5):1330. doi: 10.3390/nu12051330.
4
Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.肺炎衣原体感染加速载脂蛋白E缺乏小鼠的动脉粥样硬化进程。
J Infect Dis. 1999 Jul;180(1):238-41. doi: 10.1086/314855.
5
The stressful condition as a nutritionally dependent adaptive dichotomy.作为营养依赖型适应性二分法的应激状态。
Nutrition. 1999 Apr;15(4):305-20. doi: 10.1016/s0899-9007(99)00009-x.
6
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.阿奇霉素用于冠心病合并肺炎衣原体感染血清学证据患者的随机二级预防试验:冠心病阿奇霉素治疗:清除衣原体心肌感染(ACADEMIC)研究
Circulation. 1999 Mar 30;99(12):1540-7. doi: 10.1161/01.cir.99.12.1540.
7
The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae.衣原体的致动脉粥样硬化作用取决于血清胆固醇,且具有肺炎衣原体特异性。
J Clin Invest. 1999 Mar;103(5):747-53. doi: 10.1172/JCI4582.
8
Toll, a new piece in the puzzle of innate immunity.Toll,先天免疫难题中的一个新元素。
J Exp Med. 1999 Feb 15;189(4):605-9. doi: 10.1084/jem.189.4.605.
9
Atherosclerosis--an inflammatory disease.动脉粥样硬化——一种炎症性疾病。
N Engl J Med. 1999 Jan 14;340(2):115-26. doi: 10.1056/NEJM199901143400207.
10
Chlamydia pneumoniae and cardiovascular disease.肺炎衣原体与心血管疾病
Emerg Infect Dis. 1998 Oct-Dec;4(4):571-9. doi: 10.3201/eid0404.980407.